Consumer Cyclical
Live Price
Offline$1.16
+0.00% today
1Y Change
-20.00%
Window
Jun 25, 2025 β Jun 18, 2026
Coverage: 247 bars Β· Jun 25, 2025 β Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
MEDIROM Healthcare Technologies Inc. (MRM) is a Consumer Cyclical stock with a market cap of $980.00M and listed on NASDAQ. The stock last traded around $1.16 and down 20.0% across the available one-year price window (Jun 25, 2025 β Jun 18, 2026). Baseline metrics include revenue growth of -92.4%, EPS growth of -74.5%, a dividend yield of 0.0%. What stands out right now is revenue -92.4%, EPS -74.5%, free cash flow 0.0% with operating margin 10.3% and ROIC 1.7%. Valuation is more restrained than many high-expectation growth names at P/E 25.8 and price/sales 1.5. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines MRM price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Cyclical peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-92.4% vs +7.5% peer median
Operating Margin
Near sector median
+10.3% vs +8.4% peer median
P/E
Above sector median
25.8 vs 18.1 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 5, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -92.4% and EPS is at -74.5%, with operating margin around 10.3%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -5.2% over the next 5 trading days and finished higher after 0 of those reports.
| Quarter | EPS Ξ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 5, 2026 | β | +0.8% | -14.2% | -0.8% |
2025 Apr 29, 2025 | β | -4.1% | -0.8% | -9.0% |
2024 Jun 30, 2024 | β | -4.1% | -0.8% | -9.0% |
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
MRM
β
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
MRM Max Drawdown
-69.05%
Trailing 1Y
SPY Max Drawdown
β
Trailing 1Y
Uses the longest available daily history for MRM and SPY.

Company Overview
MEDIROM Healthcare Technologies Inc.
NASDAQ Capital Market
MEDIROM Healthcare Technologies Inc. provides holistic healthcare services in Japan. It operates in two segments, Relaxation Salon and Digital Preventative Healthcare. The Relaxation Salon segment owns and franchises relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual services, including anti-fatigue therapy, athletic support therapy, slim-down therapy, and reflexology. As of December 31, 2021, this segment operated 312 relaxation salons under the Re.Ra.Ku and Ruam Ruam brand. The Digital Preventative Healthcare segment offers government-sponsored Specific Health Guidance program, utilizing Lav, its internally developed on-demand health monitoring smartphone application; MOTHER Tracker for fitness applications; and preventative healthcare services utilizing its digital application and devices. MEDIROM Healthcare Technologies Inc. also operates Re.Ra.Ku College that offers continuing training for franchise owners, home office staff, and salon staff covering topics, such as customer service, salon operations, and relaxation techniques located in the Odaiba area in Tokyo. The company was formerly known as MEDIROM Inc. and changed its name to MEDIROM Healthcare Technologies Inc. in March 2020. MEDIROM Healthcare Technologies Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.
Valuation, growth, profitability, and balance sheet signals.
Company announcements and filings-style updates.
Next Step
After the overview, the strongest next step is usually chart context or a tighter compare set.